Managing type 2 diabetes: targeting a microbial enzyme as a novel treatment option (2023)

First Author: Keller-Pintér A
Attributed to:  BBSRC Institute Strategic Programme: Food Microbiome and Health (FMH) Partner grant funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41392-023-01694-z

Publication URI: http://dx.doi.org/10.1038/s41392-023-01694-z

Type: Journal Article/Review

Parent Publication: Signal Transduction and Targeted Therapy

Issue: 1